Coulouarn et al. showed that cHCC-CCA exhibits stem/progenitor features on a molecular level, a downregulation of the hepatocyte differentiation program and a commitment to the biliary lineage mainly driven by TGFbeta- and Wnt/beta-catenin pathways. This evidence concerns the gene CTNNB1 and cholangiocarcinoma.